Patrick L. Garcia

1.6k total citations
30 papers, 1.3k citations indexed

About

Patrick L. Garcia is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Patrick L. Garcia has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Patrick L. Garcia's work include Protein Degradation and Inhibitors (8 papers), DNA Repair Mechanisms (6 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Patrick L. Garcia is often cited by papers focused on Protein Degradation and Inhibitors (8 papers), DNA Repair Mechanisms (6 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Patrick L. Garcia collaborates with scholars based in United States, Switzerland and France. Patrick L. Garcia's co-authors include Pavel Janščák, Karina J. Yoon, Aubrey L. Miller, Stephen C. West, Josef Jiricny, Yilun Liu, Nurten Saydam, Radhakrishnan Kanagaraj, Eddy S. Yang and James E. Bradner and has published in prestigious journals such as Nucleic Acids Research, The EMBO Journal and PLoS ONE.

In The Last Decade

Patrick L. Garcia

29 papers receiving 1.3k citations

Peers

Patrick L. Garcia
Sarah E. Golding United States
Candace A. Gilbert United States
Else Munthe Norway
Gretchen M. Unger United States
Giacomo Buscemi Italy
Inken Wierstra Germany
Angela Amato Italy
Satoshi Kaneko Japan
Chris Proffitt United States
Sarah E. Golding United States
Patrick L. Garcia
Citations per year, relative to Patrick L. Garcia Patrick L. Garcia (= 1×) peers Sarah E. Golding

Countries citing papers authored by Patrick L. Garcia

Since Specialization
Citations

This map shows the geographic impact of Patrick L. Garcia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick L. Garcia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick L. Garcia more than expected).

Fields of papers citing papers by Patrick L. Garcia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick L. Garcia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick L. Garcia. The network helps show where Patrick L. Garcia may publish in the future.

Co-authorship network of co-authors of Patrick L. Garcia

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick L. Garcia. A scholar is included among the top collaborators of Patrick L. Garcia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick L. Garcia. Patrick L. Garcia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garcia, Patrick L., et al.. (2025). Cutaneous Squamous Cell Carcinoma While on Vismodegib Therapy for Locally Advanced Basal Cell Carcinoma. Actas Dermo-Sifiliográficas. 117(1). 104500–104500.
2.
Falany, Charles N., Patrick L. Garcia, Mohammed Iqbal Hossain, & Robert C.A.M. van Waardenburg. (2023). Human cytosolic steroid sulfotransferases: Versatile and rapid activity assays. Methods in enzymology on CD-ROM/Methods in enzymology. 689. 332–352. 2 indexed citations
3.
Miller, Aubrey L., Patrick L. Garcia, Dongquan Chen, et al.. (2021). The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer. Cancers. 13(14). 3470–3470. 20 indexed citations
4.
Miller, Aubrey L., Patrick L. Garcia, & Karina J. Yoon. (2020). Developing effective combination therapy for pancreatic cancer: An overview. Pharmacological Research. 155. 104740–104740. 54 indexed citations
5.
Garcia, Patrick L., Aubrey L. Miller, & Karina J. Yoon. (2020). Patient-Derived Xenograft Models of Pancreatic Cancer: Overview and Comparison with Other Types of Models. Cancers. 12(5). 1327–1327. 47 indexed citations
6.
Miller, Aubrey L., et al.. (2020). Development of gemcitabine-resistant patient-derived xenograft models of pancreatic ductal adenocarcinoma. Cancer Drug Resistance. 3. 572–585. 6 indexed citations
7.
Miller, Aubrey L., Patrick L. Garcia, Robert C.A.M. van Waardenburg, et al.. (2019). The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models of pancreatic ductal adenocarcinoma to PARP inhibitors. EBioMedicine. 44. 419–430. 84 indexed citations
8.
Hossain, Mohammed Iqbal, Jun Hee Lee, Patrick L. Garcia, et al.. (2019). SULT4A1 Protects Against Oxidative-Stress Induced Mitochondrial Dysfunction in Neuronal Cells. Drug Metabolism and Disposition. 47(9). 949–953. 18 indexed citations
9.
Miller, Aubrey L., et al.. (2019). The combination of BET and PARP inhibitors is synergistic in models of cholangiocarcinoma. Cancer Letters. 468. 48–58. 31 indexed citations
10.
Maio, Michele, George Coukos, Soldano Ferrone, et al.. (2018). Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy. Cancer Immunology Immunotherapy. 68(1). 1–9. 8 indexed citations
11.
Cramer, Stuart, Aubrey L. Miller, Joseph G. Pressey, et al.. (2018). Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft Study. Frontiers in Oncology. 7. 327–327. 12 indexed citations
12.
Garcia, Patrick L., Aubrey L. Miller, John D. Christein, et al.. (2017). JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma. Molecular Cancer Therapeutics. 17(1). 107–118. 30 indexed citations
13.
Garcia, Patrick L., Mohammed Iqbal Hossain, Shaida A. Andrabi, & Charles N. Falany. (2017). Generation and Characterization of SULT4A1 Mutant Mouse Models. Drug Metabolism and Disposition. 46(1). 41–45. 23 indexed citations
14.
Garcia, Patrick L., John D. Christein, J. Pablo Arnoletti, et al.. (2013). Development and Histopathological Characterization of Tumorgraft Models of Pancreatic Ductal Adenocarcinoma. PLoS ONE. 8(10). e78183–e78183. 24 indexed citations
15.
Saydam, Nurten, Radhakrishnan Kanagaraj, Patrick L. Garcia, et al.. (2007). Physical and functional interactions between Werner syndrome helicase and mismatch-repair initiation factors. Nucleic Acids Research. 35(17). 5706–5716. 37 indexed citations
16.
Kanagaraj, Radhakrishnan, et al.. (2006). Human RECQ5β helicase promotes strand exchange on synthetic DNA structures resembling a stalled replication fork. Nucleic Acids Research. 34(18). 5217–5231. 105 indexed citations
17.
Wu, Leonard, Kok‐Lung Chan, Christine Ralf, et al.. (2005). The HRDC domain of BLM is required for the dissolution of double Holliday junctions. The EMBO Journal. 24(14). 2679–2687. 143 indexed citations
18.
Garcia, Patrick L.. (2004). RPA alleviates the inhibitory effect of vinylphosphonate internucleotide linkages on DNA unwinding by BLM and WRN helicases. Nucleic Acids Research. 32(12). 3771–3778. 21 indexed citations
19.
Garcia, Patrick L., Yilun Liu, Josef Jiricny, Stephen C. West, & Pavel Janščák. (2004). Human RECQ5β, a protein with DNA helicase and strand‐annealing activities in a single polypeptide. The EMBO Journal. 23(14). 2882–2891. 175 indexed citations
20.
Garcia, Patrick L., et al.. (1995). Simultaneous combination of microtubule depolymerizing and stabilizing agents acts at low doses. Anti-Cancer Drugs. 6(4). 533–544. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah E. Golding Breakdown of academic impact, for papers by Candace A. Gilbert Breakdown of academic impact, for papers by Else Munthe Breakdown of academic impact, for papers by Gretchen M. Unger Breakdown of academic impact, for papers by Giacomo Buscemi Breakdown of academic impact, for papers by Inken Wierstra Breakdown of academic impact, for papers by Angela Amato Breakdown of academic impact, for papers by Satoshi Kaneko Breakdown of academic impact, for papers by Chris Proffitt
Rankless by CCL
2026